Full-Time

Associate Director Business Performance & Customer Insights Strategy

Bpci

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

Compensation Overview

$195.7k - $251.3k/yr

+ Bonus + Stock-based long-term incentives

Senior

Tampa, FL, USA + 2 more

More locations: Thousand Oaks, CA, USA | Highland Park, IL, USA

Flexible work models, including remote and hybrid work arrangements, where possible.

Category
Project Management
Strategy Development
Business & Strategy
Required Skills
Blockchain
Data Analysis
Requirements
  • Doctorate degree and 3 years of experience OR
  • Master’s degree and 7 years of experience OR
  • Bachelor’s degree and 9 years of experience OR
  • Associate’s degree and 12 years of experience OR
  • High school diploma / GED and 14 years of experience
  • Minimum of 3 years experience directly managing people and/or leadership experience leading teams, projects, programs, or directing the allocation of resources.
Responsibilities
  • Deliver actionable business insights – synthesizing insights to guide / drive business decisions and strategies
  • Using third-party vendors to deliver high quality, actionable business insights that support data-informed decisions; sometimes playing a consultative and integrating role for locally-led projects
  • Lead and manage team responsible for analytics, insights, and order to cash activities.
  • Assess Trade channel strategy effectiveness by analyzing metric data (e.g., KPIs) to drive performance and identify improvement opportunities
  • Effectively collaborate with multiple key partners across the various business units to define strategies and processes that scale across current and future Trade channel growth
  • Deliver informative analytics quantifying Trade channel strategy effectiveness to commercial, finance and supply chain leadership
  • Collaborate with Forecasting teams to ensure impact of Trade Channel related events and initiatives are accurately dialed in the forecast
  • Monitor trade partner & specialty pharmacy programs and trends, collaborate with Market Access, Marketing and Sales to recommend management strategies to drive patient compliance and adherence
  • Partner with and act as point of contact with BUs to develop, implement and track pivotal initiatives that improve upon the current business
  • Create, implement and track initiatives across the Trade organization that help inform and align business towards effective channel impact, fostering an environment of tracking value across Trade business
  • Objective when presenting insights and guiding decision-making; create influential presentation skills by pairing sound analytics with storytelling
  • Provide regular reports and data-driven recommendations to improve customer experience
  • Communicate strategic priorities and assist in diagnosing and solving tactical problems that limit desired business outcomes.
  • Review transactional backlogs, risk and issue areas, and proactively plan mitigation.
  • Understand customer pain-points related to self-service that result in fallout or voice calls and partner with Product team, Customer Journeys, Service Delivery teams, and other areas to resolve these issues and to improve customer adoption of self-service.
  • Enforces accurate and compliant execution of Amgen’s policies and procedures (SOX, Quota, Quarter-end management)
  • Provide Customer Relations Management (CRM) analytics and reporting
  • Develop and lead change management activities to drive implementation of critical initiatives
  • Work with leaders to define success measures & metrics. Track defined metrics to measure success of program features/IT solutions, help to analyze results
  • Build and grow a hard-working GCX-OTC blended workforce, supporting team through encouragement and by example
  • Communicate with and influence key collaborators and senior leadership regarding matters of significant importance like Employee and Customer Experience, prioritization and risk/issue management
  • Ensure alignment between cross-functional and cross-regional teams and supply chain strategy elements, and drive progress toward the future technology roadmap including influencing solution, supporting scenario assessment, and driving business performance optimization to ensure customer service capabilities remain first in class and in alignment with strategic goals and objectives
  • Stay updated on internal / external landscape and market trends to bring innovate solutions to meet business and customer needs
  • Lead strategic initiatives to craft functional and customer experience strategy (short, mid, and long-term horizon) using inputs from site leadership, the Supply Chain functional team, emerging industry trends, and network partner functions.
  • Partner across the organization to develop action plans and enhancement recommendations
  • Enable Amgen to continue to bring to market ground-breaking innovations that enhance the customer experience using tools such as Artificial Intelligence, Cloud Solutions, and Blockchain technologies, to name a few.
Desired Qualifications
  • BS/MS Degree with 8+ years of experience leading a large service-oriented operations organization focused on customer success, revenue growth and sales.
  • 5+ years of experience working with SAP Order to Cash processes, Sales Order Management, Pricing, Delivery, and Billing in a functional/project lead role.
  • Minimum of 3+ years overseeing full lifecycle, end-to-end SAP Order to Cash implementations, including hands-on design and configuration experience.
  • At least 2 years’ BPO industry experience working in a supervisory role with the ability to collaborate with global cross-functional and cross-regional teams.
  • Must be enthusiastic, self-motivated, high-energy and a driven problem solver – especially in face of resistance or setbacks.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and address critical health challenges through its innovative therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.